Navigation Links
Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
Date:10/6/2009

g delivery deals by value since 2000

Most active drug delivery dealmakers since 2000

The leading drug delivery partnering resources

In Drug Delivery Partnering Agreements in Pharma and Biotech, the available contracts are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Overview of drug delivery dealmaking

2.1. Introduction

2.2. The anatomy of drug delivery partnering

2.3. Drug delivery or specialty pharma?

2.3.1. Is specialty pharma the only way for drug delivery?

2.3.2. Best practice for optimizing drug delivery program development

2.2.3. The anatomy of a drug delivery deal

2.2.3.a. Case study 1: Alpharma - Durect - September 2008

2.2.3.b. Case study 2: Bayer - MDRNA - August 2007

2.2.3.c. Case study 3: Aradigm - Lung Rx - August 2007

Chapter 3 - Trends in drug delivery dealmaking

3.1. Introduction

3.2. Drug delivery partnering since 2000

3.3. Most active drug delivery dealmakers

3.4. Bigpharma drug delivery dealmaking activity

3.5. Bigpharma not active in drug delivery

3.6. Drug delivery partnering by deal type

3.6.1. Option and evaluation drug delivery partnering

3.7. Drug delivery partnering by disease type

3.8. Drug delivery M&A activity since 2000

Chapter 4 - Leading drug delivery deals

4.1. Introduction

4.2. Top drug delivery deals by value

4.3. Top drug delivery involving bigpharma


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
5. Study Shows Intradigms RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
8. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
9. Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
10. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
11. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
(Date:6/29/2015)... ... June 29, 2015 , ... Brittenford Systems, a ... and other growing businesses across the United States, has announced that it has ... the fifth consecutive year. , Based on company revenue and number of employees, ...
(Date:6/29/2015)... Church, VA (PRWEB) , ... June 29, 2015 ... ... Optimizing Interaction with Medical Devices , **FDAnews Webinar**, July 16, 2015 — 1:30 ... manufacturers to help ensure the application of human factors engineering to the design ...
(Date:6/29/2015)... ... ... across the country give their coworkers and families gifts all the time. From holiday exchanges ... often do coworkers donate “life” to the husband of a coworker? For one VA employee, ... told me her husband was on a donor list,” Glenshaw resident Kathi Dahl said. “I ...
(Date:6/29/2015)... ... June 29, 2015 , ... Two multicounty ... C.R. Bard, Inc. and Ethicon, Inc. continue to move forward in New Jersey’s ... Conference is to be convened on Thursday, July 23rd at 12:00 p.m. (In ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... to healthcare providers for patients with certain neuropsychiatric and chronic pain conditions, has ... and CEO. , The appointments include: Peter Donato, Senior Vice President, Chief Financial ...
Breaking Medicine News(10 mins):Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:VA Pittsburgh Employee Donates Kidney to Coworker’s Spouse 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3
... a bewildering array of regulatory DNA sequences interacting with a ... which genes are active when and where. Understanding how ... past decades but we are now starting to make significant ... how the entire complexity evolves to give differences in the ...
... giving up smoking after a programme involving sending motivational and ... months. , The findings of the txt2stop trial, which was ... and funded by the Medical Research Council, are published in ... innovative approach to the deadly problem of smoking, which is ...
... Current or heavy smokers who were screened with low-dose spiral ... deaths from lung cancer than did those who were screened ... clinical trial that involved more than 53,000 people. The ... in individuals at high risk of developing lung cancer to ...
... 29, 2011) A new treatment option may soon ... published in the July issue of The Journal ... that combined positron emission tomography and X-ray computed tomography ... refractory or relapsed high-risk neuroblastoma for treatment with a ...
... News) -- A new study reveals that 90 percent of ... started smoking, drinking or using drugs before they were 18 ... Americans who began using any addictive substance before age 18 ... using an addictive substance when they were 21 or older. ...
... cancer has provided the most comprehensive and integrated view of ... adenocarcinoma tumors from 500 patients were examined by The Cancer ... the June 30, 2011, issue of Nature . ... cancer, accounting for about 85 percent of all ovarian cancer ...
Cached Medicine News:Health News:Many a mickle makes a muckle: How changes in animals' size and shape arise 2Health News:Text message support for smokers doubles quit rates 2Health News:Screening with low-dose spiral CT scanning reduces lung cancer deaths by 20 percent 2Health News:Screening with low-dose spiral CT scanning reduces lung cancer deaths by 20 percent 3Health News:New therapy for childhood neuroblastoma proves feasible and safe 2Health News:Addiction Starts Early in American Society, Report Finds 2Health News:Addiction Starts Early in American Society, Report Finds 3Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 2Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 3
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: